These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 30642195)

  • 1. Silicone oil droplets in repackaged anti-vascular endothelial growth factors for intravitreal injections: In search of the main source of contamination.
    Olea JL; Gómez-Resa M; Cervera-Peris MM; Aragón JA
    Eur J Ophthalmol; 2020 Jul; 30(4):774-779. PubMed ID: 30642195
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CONTAMINATION OF ANTI-VEGF DRUGS FOR INTRAVITREAL INJECTION: How Do Repackaging and Newly Developed Syringes Affect the Amount of Silicone Oil Droplets and Protein Aggregates?
    Schargus M; Werner BP; Geerling G; Winter G
    Retina; 2018 Oct; 38(10):2088-2095. PubMed ID: 28841584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective Study of Silicone Oil Microdroplets in Eyes Receiving Intravitreal Anti-Vascular Endothelial Growth Factor Therapy in 3 Different Syringes.
    Thompson JT
    Ophthalmol Retina; 2021 Mar; 5(3):234-240. PubMed ID: 32735904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence of Presumed Silicone Oil Droplets in the Vitreous Cavity After Intravitreal Bevacizumab Injection With Insulin Syringes.
    Khurana RN; Chang LK; Porco TC
    JAMA Ophthalmol; 2017 Jul; 135(7):800-803. PubMed ID: 28617905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Silicone oil-free syringes, siliconized syringes and needles: quantitative assessment of silicone oil release with drugs used for intravitreal injection.
    Melo GB; da Cruz NFS; do Monte Agra LL; Emerson GG; Lima LH; Linkuviene V; Maia M; Farah ME; Carpenter JF; Rodrigues EB; Probst C
    Acta Ophthalmol; 2021 Dec; 99(8):e1366-e1374. PubMed ID: 33890418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new method for pharmaceutical compounding and storage of anti-VEGF biologics for intravitreal use in silicone oil-free prefilled plastic syringes.
    Lode HE; Gjølberg TT; Foss S; Sivertsen MS; Brustugun J; Andersson Y; Jørstad ØK; Moe MC; Andersen JT
    Sci Rep; 2019 Dec; 9(1):18021. PubMed ID: 31792234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bevacizumab for Intravitreal Injection: Impact of Sub-Visible Particles on the Shelf-Life of Repackaged Bevacizumab.
    Crul M; Zandvliet A; Moes JR; Veenbaas T; Smeets O
    J Ocul Pharmacol Ther; 2019; 35(6):372-375. PubMed ID: 31259653
    [No Abstract]   [Full Text] [Related]  

  • 8. PARTICULATE MATTER FROM SYRINGES USED FOR INTRAVITREAL INJECTIONS.
    Dounce SM; Laskina O; Goldberg RA
    Retina; 2021 Apr; 41(4):827-833. PubMed ID: 32956210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Silicone oil microdroplets and protein aggregates in repackaged bevacizumab and ranibizumab: effects of long-term storage and product mishandling.
    Liu L; Ammar DA; Ross LA; Mandava N; Kahook MY; Carpenter JF
    Invest Ophthalmol Vis Sci; 2011 Feb; 52(2):1023-34. PubMed ID: 21051703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravitreal silicone oil droplets after intravitreal drug injections.
    Bakri SJ; Ekdawi NS
    Retina; 2008; 28(7):996-1001. PubMed ID: 18698303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term stability of bevacizumab repackaged in 1mL polypropylene syringes for intravitreal administration.
    Paul M; Vieillard V; Roumi E; Cauvin A; Despiau MC; Laurent M; Astier A
    Ann Pharm Fr; 2012 May; 70(3):139-54. PubMed ID: 22655582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of Syringes With Intravitreal Anti-VEGF Drugs: Particle Burden and Protein Aggregates in Brolucizumab, Aflibercept and Bevacizumab.
    Schargus M; Kopp KT; Helbig C; Frings A; Winter G
    Transl Vis Sci Technol; 2021 Aug; 10(9):21. PubMed ID: 34406342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LARGE SILICONE DROPLETS AFTER INTRAVITREAL BEVACIZUMAB (AVASTIN).
    Avery RL; Castellarin AA; Dhoot DS; Pieramici DJ; Nasir MA; Steinle NC; Avery LP; Gordon GM
    Retin Cases Brief Rep; 2019 Spring; 13(2):130-134. PubMed ID: 28301412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LONG-TERM PHYSICAL STABILITY, STERILITY, AND ANTI-VEGF BIOACTIVITY OF REPACKAGED BEVACIZUMAB IN 2-ML GLASS VIALS.
    Peterson JS; Rockwell K; Scott IU; Ip MS; VanVeldhuisen PC; Blodi BA;
    Retina; 2019 Sep; 39(9):1802-1809. PubMed ID: 29746405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Silicone oil droplets after intravitreal bevacizumab injection in two patients.
    Caroca JO; Caroca JIO
    Arch Soc Esp Oftalmol (Engl Ed); 2020 Jun; 95(6):e43. PubMed ID: 32376125
    [No Abstract]   [Full Text] [Related]  

  • 16. SCORE Study Report 7: incidence of intravitreal silicone oil droplets associated with staked-on vs luer cone syringe design.
    Scott IU; Oden NL; VanVeldhuisen PC; Ip MS; Blodi BA; Antoszyk AN;
    Am J Ophthalmol; 2009 Nov; 148(5):725-732.e7. PubMed ID: 19674727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the effect of syringe surfaces on protein formulations.
    Majumdar S; Ford BM; Mar KD; Sullivan VJ; Ulrich RG; D'souza AJ
    J Pharm Sci; 2011 Jul; 100(7):2563-73. PubMed ID: 21319164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of the risk of needlestick injuries associated with intravitreal injections.
    Shah SU; Koenig MJ; Dacquay Y; Mozayan A; Hubschman JP
    Retina; 2014 Apr; 34(4):781-4. PubMed ID: 23975000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Silicone Oil-Free Syringe Tailored for Intravitreal Injection of Biologics.
    Gjølberg TT; Lode HE; Melo GB; Mester S; Probst C; Sivertsen MS; Jørstad ØK; Andersen JT; Moe MC
    Front Ophthalmol (Lausanne); 2022; 2():882013. PubMed ID: 38983507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of the initial level and migration of silicone oil lubricant in empty prefilled syringes for biologics using infrared spectroscopy.
    Bee JS; Frey VV; Javed U; Chung J; Corcoran ML; Roussel PS; Krause SO; Cash PW; Bishop SM; Dimitrova MN
    PDA J Pharm Sci Technol; 2014; 68(5):494-503. PubMed ID: 25336420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.